These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

58 related items for PubMed ID: 3683326

  • 1. [Clinical significance of the ISA (intrinsic sympathomimetic activity) of the beta blocker carteolol].
    Lohmöller G, Conca W, Pötzl C.
    Med Klin (Munich); 1987 Sep 18; 82(19):647-50. PubMed ID: 3683326
    [No Abstract] [Full Text] [Related]

  • 2. [Clinical significance of intrinsic sympathomimetic activity of the beta blocker carteolol. II: Comparative studies of carteolol and pindolol in patients with bradycardia].
    Lohmöller G, Middeke M, Mrowka C, Pötzl C, Renner W, Zoller W.
    Med Klin (Munich); 1989 Feb 15; 84(2):81-5. PubMed ID: 2651861
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of essential hypertension with the beta-receptor antagonist carteolol. A multicenter study].
    Rosprich G, Sölter H.
    Arzneimittelforschung; 1983 Feb 15; 33(2a):334-9. PubMed ID: 6682326
    [No Abstract] [Full Text] [Related]

  • 4. Carteolol, an antihypertensive beta-blocker with intrinsic sympathomimetic activity, reduces ECG evidence of left ventricular hypertrophy.
    Rosales OR, Sander GE, Roffidal L, Given MB, Giles TD.
    Chest; 1989 Jan 15; 95(1):43-7. PubMed ID: 2521204
    [Abstract] [Full Text] [Related]

  • 5. [Clinical experiences in patients with coronary heart disease and angina pectoris].
    Sölter H.
    Arzneimittelforschung; 1983 Jan 15; 33(2a):304-10. PubMed ID: 6404286
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Pharmacodynamics of carteolol].
    Odenthal KP.
    Arzneimittelforschung; 1983 Jan 15; 33(2a):281-5. PubMed ID: 6132609
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Heart rate behavior and the ischemic ST-segment under carteolol hydrochloride. Dose-response relationship and duration of effect].
    Kober G, Veidt J, Mikludy R, Kaltenbach M.
    Arzneimittelforschung; 1983 Jan 15; 33(2a):313-7. PubMed ID: 6682323
    [Abstract] [Full Text] [Related]

  • 13. [Hypotensive effect of carteolol in patients with essential hypertension].
    Beythien RD.
    Arzneimittelforschung; 1983 Jan 15; 33(2a):330-3. PubMed ID: 6682325
    [Abstract] [Full Text] [Related]

  • 14. [Clinical results with carteolol in patients with arrhythmias].
    Strösser W.
    Arzneimittelforschung; 1983 Jan 15; 33(2a):339-45. PubMed ID: 6682327
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Hemodynamic studies at rest and under stress in patients with coronary heart disease after administration of carteolol].
    Saborowski F, Dundalek E, Griebenow R, Sy M.
    Arzneimittelforschung; 1983 Jan 15; 33(2a):310-2. PubMed ID: 6682322
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Time-dependent antihypertensive effect of carteolol--a beta-adrenoceptor antagonist with partial agonist activity.
    Giles TD, Sander GE, Kaneish A, Quiroz AC.
    Clin Pharmacol Ther; 1984 Mar 15; 35(3):301-6. PubMed ID: 6697637
    [Abstract] [Full Text] [Related]

  • 20. Serum creatine phosphokinase levels during treatment with beta-adrenoreceptor blocking agents.
    Saruta T, Suzuki H, Kawamura M, Itoh H.
    J Cardiovasc Pharmacol; 1985 Mar 15; 7(4):805-8. PubMed ID: 2410725
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.